Article Sidebar

Download
PDF

Main Article Content

Abstract

Introduction. Primary malignant tumors of the limbs are rare conditions. They are most common in children and adolescents. Treatment is long and costly, and requires long-term follow-up. Our aim was to describe the clinical and paraclinical results of their management in Bouake. Materials and methods. This was a cross-sectional study conducted over 8 years (January 2011 to December 2018) at the traumatology and orthopedics department of the Bouaké University Hospital. It concerned patients treated and followed up for at least 5 years for malignant tumors of the limbs. Our variables of study were sociodemographic, diagnostic, therapeutic and evolutionary. Results. Twenty-six cases were studied. Their mean age was 34.5 years. The sex ratio was 1.17. Most patients lived outside Bouaké (n=17). Tumors predominated in the pelvic limbs (n=15). They were frequent in the leg (n=11). Surgery (n=23) followed by chemotherapy (n=2) and radiotherapy (n=2) were the main therapeutic modalities. Mean theoretical follow-up was 8 years. We had were 7 live patients, 15 lost to follow-up and 4 deaths. The WHO score for living patients was 1. Conclusion. Long-term follow-up of malignant tumors of the limbs is irregular and inadequate in Bouake. Vital prognosis is poor.

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Touré YL, Sako K, Traoré-Kouassi AAD, Akobé Achié JR, Odo BA, Madiou MKA, Koffi MS, Mebiala NMP, Touré PGLK, Yapo INSB, Bouagnon PR, & Kouamé AS. (2024). 7-Year Review of the Management of Primary Malignant Tumors of The Limbs in Bouaké: A Cross-Sectional Study: Revue de la Prise en Charge des Tumeurs Malignes Primitives des Membres à Bouaké entre 2011 et 2018 : Une Étude Transversale. HEALTH SCIENCES AND DISEASE, 25(9). https://doi.org/10.5281/hsd.v25i9.6025
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. -Kone SJ, N’dah KR, Kouakou KA, et al. Primary Malignant Bones Cancers in Côte d’Ivoire: Epidemiological and Histopathological Aspects. Open Journal of Pathology 2018; 8:51-59.
  2. -Canadian Cancer Society. What is bone cancer. Disponible : http://www.cancer.ca/frca/cancer-information/cancer-type/bone/bonecancer/. Consulté le 23 Avril 2019.
  3. -Zomalhèto Z, Biaou O, Yekpe P, Gnankadja SNE, Avimadjè M. Profil des tumeurs osseuses malignes primitives de l’adulte à Cotonou (Benin). J Afr Cancer 2015; 7:100 - 3.
  4. -Berg VHD. Results of diagnostic review in pediatric bone tumors and tumorlike lesions. J Ped Orthop 2008; 28(5): 561-4.
  5. - Fletcher C D, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone (2002) (Vol. 4). IARC, Lyon.
  6. -Hawkins DS, Rajendran JG, Conrad EU, Bruckner JD, Eary JF.Evaluation of Chemotherapy Response in Pediatric Bone Sarcomas by [F-18] -fluorodeoxy-D-glucose Positron Emission Tomography. Cancer (2002), 94, 3277-3284.
  7. -Données globales d’épidemiologie des cancers. Institut National du cancer
  8. https://www.e-cancer.fr// consulté le 13/10/2023
  9. - Kouassi KJE, Akobe AJR, Kouassi AAN, Soro ZM, Krah KL, Kodo M. Aspects épidémiologiques et thérapeutiques des ostéosarcomes en milieu tropical. Rev int sc méd 2023;25(1):95-101
  10. -Alexandra K. Primary malignant tumor of the bone. Surgery (Oxford) 2015 ; 33 (1):26-33.
  11. - Dunot J, Ahrens S, Paulussen M, et al. Traitements non chirurgicaux des tumeurs des os: chimiothérapie et radiothérapie. Encycl Méd Chir : appareil locomoteur. 2001; 14 – 702.
  12. -National cancer intelligence network. Bone Sarcomas: incidence and survival rates in England. NCIN Data Briefings; sep 2010.
  13. -Cofer. Tumeur des os primitives et secondaire.5e Edition. Paris : Elsevier-Masson ; octobre 2015. Item 304 UE9. 35-Schubert T, Docquier P, Delloye C. Tumeurs osseuses malignes de l'appareil locomoteur. UCL, 2013 ; 11p.
  14. - Jemal A. Cancer statistics, 2009 CA Cancer J Clin. 2009; 59:225–49
  15. - Farikou I, Motah M, Ngo NB, et al. Prise en charge des tumeurs osseuses au Cameroun. Notre expérience initiale. Health Sci Dis 2011 ;12(2) : 6-
  16. - van den Berg H, Kroon HM, Slaar A .Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration ‘PALGA’ . J Pediatr Orthop 2008; 28:29-35.
  17. - Rajiv R.Treatment of bone tumors .Surg pathol clin 2012 5(1):301-18
  18. -Grimer R. World health organization classification of tumor of soft tissue and bone. Lyon IARC Press 2013 ;6:244-5.
  19. -Baker LH .Soft Tissue and Bone Sarcomas: A disease State Overview The Practicing Oncologist’s Perspective.2010;6:1-6
  20. -Oumar N, Desire M A, Mbaye F, et al. Aspectsépidemiologiques, diagnostiques et thérapeutiques des ostéosarcomes de l’enfant au CHU Aristide le Dantec de Dakar : à propos de 16 cas. Pan African Medical Journal. 2013; 14: 104.
  21. - Peko JF, Gombe-Mbalawa A .Aspects épidémiologiques et anatomopathologiques des cancers primitifs des os à Brazzaville. Mali Méd 2003;18(1):43-4.
  22. - Athanasou N,Bielack S,De Alava E, et al .Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up .Annals of Oncology.2010;21(5): 204–13
  23. -Leavey PJ, Collier AB .Ewing sarcoma: prognostic criteria, outcomes and future treatment. Expert Rev Anticancer Ther 2008(8):617–24
  24. -Visuri TI, Pukkala E, Pulkkinen P, Paavolainen P. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings .Proc Inst Mech Eng H 2006;220(2):399-407.
  25. - Yao LB, Akobe AJR, Séry BNJL, M’bra K I et al. Mortalité en Orthopédie-Traumatologie : aspects épidémiologiques et facteurs de risques. Rev int sc méd 2021;23,1:55-62.